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Abstract
Fumonisin Bj is a mycotoxin produced by fungi of the genus Fusarium, common pathogens of corn and other grain plants.
effects associated with fumonisin Bjinclude equine leukoencephalomacia, porcine pulmonary edema, rat renal carcinor ,a, and murine hepatocellular carcinoma. Increased risk for esophageal cancer in humans has been epidemiologically assoc ated with consumption of corn contaminated with Fusarium, suggesting that fumonisin Bj may be involved. The biological
effects of fumonisin Bj exposure result primarily from disruption of de novo sphingolipid biosynthesis via inhibition ofceramide
s/nthase. Exposure of animals or cultured cells to fumonisin Bjresults in the characteristic accumulation of sphinganine, a toxic
sphingolipid intermediate, concomitant with depletion of essential complex sphingolipids.
Ceramide synthase has not been purified to homogeniety and characterized. We prepared crude ceramide synthase from
detergent-extracted rat liver homogenates using PEG-precipitation and cation exchange chromatography. Ceramide synthase
activity was then sequestered, using fumonisin Bj covalently coupled to POROS-NH# particles, and eluted selectively. The
observed 119-fold enrichment in specific activity demonstrates the utility of fumonisin-POROS affinity chromatography in the
purification of ceramide synthase.
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Introduction
Fumonisin Bj (FBI) is a toxin produced by members of
fungal genus Fusarium (Gelderblom et al., 1988; Thiel et
., 1991). Fusarium moniliforme, a common source of FBI, is
typical fungal contaminant of economically important
ereal crops. The infection of corn with Fusarium, particuarly problematic after periods of drought-induced stress folowed by warm, moist weather, produces ear rot and stalk
t diseases that can be devastating to crop productivity
chaafsma et al., 1993).
FBI produces diverse pathological effects in animals
nsuming FBI-contaminated food. FBI causes equine
ikoencephalomacia in horses (Marasas et al., 1988), pulanary edema in swine (Harrison et al., 1990), immunoppression in turkey poults (Li et al., 2000), and renal toxty in rabbits (Gumprecht et al., 1995; Bucci et al., 1998).
'o-year FBI exposure studies in rodents, funded by the
itional Toxicology Project and performed at the National
inter for Toxicological Research, were recently completThese studies demonstrated that dietary exposure to
•1 produced
hepatic carcinoma in female B6C3Fj/NCTR
ce and renal carcinoma in male Fischer 344/NCTR rats
oward et al., 1999). Epidemiological studies have associ;d the consumption of corn contaminated with Fusarium
th esophageal cancer in humans (Marasas et al., 1988;
lu and Li,1994).
Disruption of sphingolipid biosynthesis via inhibition of
mide synthase appears to be the principal biochemical
:t of exposure to FBI (reviewed in Merrill et al., 1995).
le
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FB 1 is structurally similar to the sphingoid base substrates of
the ceramide synthase catalyzed reaction (Fig. 1).
Sphinganine, an acyl group acceptor substrate for the
ceramide synthase catalyzed reaction, accumulates rapidly
in cultured cells or tissues exposed to FBI. Ceramides can
be liberated from complex sphingolipids via enzymatic
hydrolysis or produced via de novobiosynthesis through the
ceramide synthase catalyzed reaction. Increased ceramide
levels produced by either mechanism have been associated
with apoptosis (Mathias et al., 1998). Blocking the ceramide
synthase catalyzed N-acylation of sphinganine by FB 1 also
causes depletion of complex sphingolipid pools, including:
dihydroceramides, ceramides, glucosylceramides, sphingomyelin, gangliosides, cerebrosides, and sulfatides.
Maintenance of complex sphingolipid pools are important
for cell survival and depletion of complex sphingolipids
contributes to FBI toxicity (Yoo et al., 1996; Tolleson et al.,
1999).
The regulation of ceramide synthase catalytic activity
must be critical for cell survival because it affects the concentrations of sphingolipid mediators that influence cell survival and death processes. Furthermore, signal transduction
pathways regulating ceramide synthase gene expression and
its enzymatic activity may exert an effect on the homeostatic balance of strategic sphingolipids. The first step in
understanding the biochemical nature of ceramide biosynthesis is the isolation of the active enzyme. Several groups
have reported the partial purification of ceramide synthase,
but none have been successful in completing its isolation to
homogeniety. We endeavored to test a FBI affinity chro-
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Materials and methods

Fig. 1. Structures of fumonisin Bj,sphinganine, sphingosine,
and N-palmitoylsphingosine, depicting stereochemical similarities.

matography column for isolating fumonisin-binding proteins expected to be present in rat liver. We previously discovered that our FBI affinity column sequestered rat liver
argininosuccinate synthetase from rat liver extracts and that
both rat liver and recombinant human argininosuccinate
synthetases are inhibited by FBI in vitro(Ki'= 6 mM and 35
mM for human and rat liver argininosuccinate synthetase,
respectively; Jenkins et al., 2000). Although ceramide synthase is believed to represent the most significant target for
the biological action of FBI, other enzyme systems are
affected by FBI. Fukuda et al. (1996) showed that FBI
inhibits recombinant rat protein phosphatase 5 (PP5) with
an IC50 of 80 |iM and PPly2, PP2A, PP2B, and PP2C with
IC50 values 300-1000 uM. PP5 is reportedly expressed in
many tissues, including hepatocellular carcinoma cell lines,
but itis poorly expressed innormal liver samples and would
not be expected in the sample used in this study (Shirato et
al., 2000). We predicted that ceramide synthase or other
FBI-binding proteins could be recovered from rat liver
extracts using FB1 affinity chromatography.

Sample Preparation.--^ sample processing and chn >matographic procedures were performed at 4°C except
where indicated. Rat liver extract was prepared by mechai iical distruption (Polytron, Brinkmann Instrumen s
Company, Westbury, NY) of frozen rat livers in 50 mM
sodium phosphate buffer, pH 6.5 containing 10 mMEDTA,
150 mM sodium chloride, and 2% Triton X-100™ followed
by 30 min incubation at 0°C. Cellular debris and other
insoluble matter was removed by centrifugation for 15 mi i
at 21,000g. Polyethylene glycol (PEG) was added to 10%
(w/v) to the supernatant and contaminating proteins were
removed from the rat liver detergent extract by precipitation and centrifugation. Ceramide synthase activity was
precipitated by increasing the PEG concentration to 20%.
In some cases rat liver cytosol was prepared by disrupting
rat liver samples in the absence of detergents, then removing cellular debris and organelles by high speed centrifugation, adding Triton X100 to 2% and preparing cytosolic 1020% PEG fractions. The 10-20% PEG precipitates were
collected by centrifugation and redissolved in 25 mM sodium phosphate buffer, pH 6.5 containing 1 mMEDTA and
2% Triton X-100, and applied to a 5x20 cm SP-Sepharose
strong cation exchange column. Ceramide synthase activity
was eluted from the cation exchange column using an
increasing pH and salt gradient (linear gradient from 0-40%
Buffer B over 120 min; flow rate 3.0 mL/min; Buffer A:25
mM sodium phosphate, 1 mMEDTA, 0.2% Brij-35, pH 6.5;
Buffer B: 25 mM sodium phosphate, ImM EDTA, 0.2%
Brij-35, 2.0 Msodium chloride, pH 7.5). Fractions containing ceramide synthase activity were pooled and dialyzed
twice against 50 volumes of 50 mM sodium phosphate, 1
mM EDTA, 0.2% Brij-35, pH 6.8.
POROS-FB1 Affinity Chromatography. -The POROS
FBI affinity matrix was prepared by coupling FBI tricarbyllate groups to free primary amine groups on 20 um
POROS-NH™ particles (Perceptive Biosystems, Foster City,
CA), as previously described (Newkirk etal., 1998; Jenkins et
al., 2000). A suspension of POROS-FB1 matrix was slurry
packed into a 0.46 cm x 10.0 cm polymer column jacket fitted with 2 |im end frits and installed into a Varian ProStar
biocompatible HPLC system equipped with a Varian
ProStar variable wavelength UV/Vis detector, a BioRad
Econo Gradient monitor, and a BioRad Model 2128 fraction
collector. Data were collected and processed using
Maclntegrator II Software (Varian) and a Macintosh
Quadra personal computer, which also provided control for
the pump units.
The POROS-FB1 affinity column was equilibrated in
dialysis buffer and loaded at 4 mL/min. Ceramide synthase
activity was eluted from the POROS-FB1 column using a
two-step gradient of increasing ionic strength (linear gradient from 0-25% Buffer B from 0-10 minutes, 25-100% Buffer
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g rom 10-15 min; flow rate 4 mL/min; Buffer A: 50 mM
1 mM EDTA, 0.2% Brij-35, pH 6.8;
s( ium phosphate,
B fer B: 2.0 Msodium chloride dissolved in Buffer A).
Analytical Procedures.-Protein
concentrations were
d ermined using the Pierce BCA Protein Assay Kit with
b /ine serum albumin standards (Pierce Endogen,
R ckford, IL) according to the manufacturer's specificati is. Denaturing polyacrylamide gel electrophoresis was
p formed using 4-20% gradient Ready Gels (BioRad,
H rcules, CA) with BioSafe Coomassie Stain. Ceramide
s\ ithase activity was measured using the method described
b Hirshberg et al. (1993) and adapted slightly for our use
(jmkins et al., 2000). Assay reactions were performed in 50
mM sodium phosphate buffer, pH 6.9. Samples were
desalted prior to activity measurements by three sequential
dilutions (1:10) with cold assay buffer and centrifugal ultrafiltration at 4°C using Ultrafree 0.5 microconcentrator
devices (10,000 MWCO, Millipore, Bedford, MA).
Desalted samples were incubated with 0.2 uCi [14C]-palmitoyl coenzyme A (60 mCi/mmole, NEN, Boston, MA) and
40 (iM D-tfry/Aro-sphingosine (Sigma Chemical Co., St.
Louis, MO) in 0.25 mL reactions for 20 min at 37°C. The
reactions were quenched by placing the tubes in an
ice/water bath for 1 min prior to extraction. Samples containing polyethylene glycol were extracted twice with 0.5
mL diethyl ether. Allother samples were extracted once
with 0.6 mL 2:1 chloroform/methanol and once with 0.4
mL chloroform. The organic extracts were dried in vacuo,
dissolved in chloroform, and applied to LK5DF silica thin
layer plates (Whatman Inc., Clifton, NJ). Thin layer chro90:7:3
matography
using
was
performed
chloroform/methanol/concentrated
ammonium hydroxide.
Authentic N-palmitoylsphingosine was included as a reference standard and visualized by post-run exposure to iodine
vapor. [14C]-N-palmitoylsphingosine reaction products were
quantified by phosphorimagining (Molecular Dynamics
Corporation, Sunnydale, CA) with ImageQuant software.
reaction rates for protein-free reactions were
btracted from all measurements. Specific activity values
ire determined by dividing the net amount of ceramide
oduct formed, expressed as volume integration counts, by
e amount of protein added to the reaction.

Iickground

Results
Ceramide

synthase activity

was detected in rat liver

detergent extracts and concentrated using polyethylene glycol precipitation (Fig. 2A). Prior work in our laboratory
determined that ceramide synthase activity could be detected in the absence of detergents. However, the addition of
detergents prevented excessive losses of ceramide synthase
through nonspecific association with heterogenous protein
precipitates (data not shown). A large amount of extraneous

Journal

Fig. 2. Extraction of ceramide synthase activity from rat
liver. (A) Ceramide synthase activity in rat liver fractions
(100 ug protein/reaction) was determined as given in
Materials and Methods. (B) Ceramide synthase activity in
cation exchange chromatography fractions. Aliquots (100
ug/reaction) from 10-20% PEG fraction (load), unretained
fraction, and retained fractions were subjected to ceramide
synthase assay as described in Materials and Methods. Insets
displayed under plots: [14C]-N-palmitoylsphingosine reaction products quantified by tic and phosphorimaging.
protein was removed by differential precipitation with PEG,
and the sample volume was reduced (Table 1). Although
the apparent specific activity appeared to be relatively
unchanged following PEG precipitation, the presence of
PEG in these samples may have interfered with enzyme catalyzed reaction. We observed that the specific activity
recovered somewhat after cation exchange chromatography
in the subsequent step (Fig. 2B). Ceramide synthase activity
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was retained by the SP-Sepharose column and eluted at 135140 min in approximately 0.35 M sodium chloride. UV
spectroscopy of the retained and nonretained fractions (data
not shown) revealed that a large amount of nonproteinaceous UV-absorbing material was removed from the redissolved 10-20% PEG fraction.
The ceramide synthase activity in the pooled and dialyzed SP-Sepharose fraction was efficiently adsorbed by the
POROS-FBl column and eluted with sodium chloride
whereas most of the extraneous protein was excluded (Fig.
3A-C). Ceramide synthase activity was not detected in the
unretained sample (Fig. 3C). The specific activity of
ceramide synthase eluted from the POROS-FBl column
increased 17-fold relative to the material applied to the column (Fig. 3C), and the protein recovery indicated a 119-fold
enrichment by this step (Table 1).
Denaturing gel electrophoresis showed that the heterogeneity of active samples correlated inversely withincreased
specific activity. The heterogeneity of the most active sample eluted from the POROS-FBl column was less than that
of rat liver homogenate, 10-20% PEG fractions, or the SPSepharose fractions (Fig. 3D). Several proteins are particularly prominent in the active fractions eluted from the
POROS-FBl column with apparent Mr of 29, 38, 51, and 74
kDa. Prior work in our laboratory resulted in the purification of a small quantity of a homogeneous 38 kDa protein
that exhibited ceramide synthase activity (data not shown).

Discussion
Scribney (1966) first described ceramide biosynthesis
(i.e., ceramide synthase) in brain and liver microsomes.
Morell and Radin (1970) determined the acyl group specificity specificity of ceramide synthase in rat brain extracts.
Later, the presence of ceramide synthase activity in liver
microsomal fractions was confirmed by Narimatsu et al.
(1986) and extended by Mandon et al. (1992) and Hirshberg
et al. (1993) who detected ceramide synthase activity
present on the cytosolic surface of the endoplasmic reticulum. Shimeno et al. (1995, 1998) also observed ceramide
synthase activity in mitochondrial fractions. Studies
performed in our laboratory confirmed that ceramide synthase activity could be detected in both fractions and that
conditions that partially disrupt organelle integrity released
ceramide synthase activity into the soluble, microsome-free
cytosolic fraction. We utilized Triton X-100 as a nondenaturing detergent to extract ceramide synthase from whole
liver homogenates.
The purification of ceramide synthase has been a daunting problem for several research groups. Shimeno et al.
(1998) employed anion exchange chromatography followed
by sphingosine affinity chromatography in the partial purification of ceramide synthase. Sphingosine was coupled to
the column matrix via its primary amine group, resulting in

Fig. 3. POROS-FBl affinity chromatography. (A) POROSFBl chromatogram. Dialyzed fraction from strong cation
exchange chromatography containing crude ceramide synthase activity was applied to 0.46x10 cm POROS-FBl column and eluted with sodium chloride. (B) Protein levels in
POROS-FBl chromatographic samples. (C) Ceramide synthase activity in POROS-FBl chromatographic samples.
Insets under plots: [14C]-N-palmitoylsphingosine reaction
products quantified by tic and phosphorimaging. (D)
Denaturing polyacrylamide gel electrophoresis of POROSFBl chromatographic samples.
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ble 1 Analysis of ceramide synthase isolation scheme

sample

protein

protein

volume

concentration

(mL)

(mg/mL)

yield
(mg)

596

37.0

22,040

,

,mogenate

i

10% PEG fraction*

174

70.5

12,300

)-2O°/o

87

31.9

2,780

331

3.04

1,010

30

16.3

490

28

3.10

86.7

83.5

0.60

50.1

4

0.18

0.73

fl

PEG fraction*

: P-Sepharose (unretained)"

SP-Sepharose (retained)

0

POROS-FB1 load*
POROS-FB1 (unretained)*
POROS-FB1 (retained)*

tese

samples and those presented in Fig. 2 are related

to processing

141 g rat liver as described in the Materials and Methods

ion.

samples and those presented in Fig. 3 are related to processing 250 g rat liver in the absence of detergent and perling a high speed centrifugation to remove nuclei, mitochondria, and microsomes prior to PEG precipitation in the presi
of detergent and SP-Sepharose chromatography. Similar results were obtained with whole liver extracts.

Kese
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interactions. The effective concentrations of these substrates
can be lowered through nonspecific adsorption to extraneous proteins in a concentration-dependent manner. Some
investigators presaturate carrier proteins with excess sphinganine (or sphingosine) for inclusion in ceramide synthase
assays in order to prevent removal of free sphinganine by
nonspecific binding. However, this results in an indeterminate amount of free and bound substrate and does not
ensure adequate concentrations of free sphingoid base substrate. Thus, reaction rates observed in ceramide synthase
activity measurements are generally dependent both on the
concentration of the enzyme and the substrate and are only
informative in a qualitative way regarding relative catalytic
activity. The purification of ceramide synthase will eventually allow accurate determinations of the rate constants of
this enzyme for its substrates and determination of inhibition constants for FB1 and related molecules.
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